Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

Join Dwight Egan, CEO of Co-Dx, for an update on the Company's growth initiatives, including its recently announced definitive agreement with Arabian Eagle in the Kingdom of Saudi Arabia to form ...

Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...

The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million in 2024. This growth is poised to accelerate, with the market projected to ...

The Chong Kun Dang Gochon Foundation announced that it has awarded the 18th Kochon Prize to Molbio Diagnostics, a molecular ...

Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...

Insight Molecular Diagnostics Inc. (($IMDX)) announced an update on their ongoing clinical study. Study Overview: The GraftAssureDx Study, ...

Investing.com -- Co-Diagnostics Inc (NASDAQ:CODX) stock plunged 54.8% Tuesday after the molecular diagnostics company announced a registered direct offering that will significantly dilute existing ...

Biostate AI, a pioneer in AI-driven molecular diagnostics, today announced that its Indian subsidiary Bayosthiti AI has partnered with Narayana Health, one of the world's largest cardiac care networks ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater ...